載入...
Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer
BACKGROUND: Our previous studies have demonstrated that transduction of human dendritic cells (DC) with adenovirus encoding secondary lymphoid chemokine, CCL21, led to secretion of biologically active CCL21 without altering DC phenotype or viability. In addition, intratumoral injections of CCL21-tra...
Na minha lista:
Main Authors: | , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
BioMed Central
2008
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2507704/ https://ncbi.nlm.nih.gov/pubmed/18644162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-6-38 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|